Recurrent Prostate Cancer: A Decision Support Guide

复发性前列腺癌：决策支持指南

• 批准号: 6649221
• 负责人: Ann E. McFarren
• 金额: $ 31.4万
• 依托单位: HEALTHMARK MULTIMEDIA, LLC
• 依托单位国家: 美国
• 财政年份: 2000
• 资助国家: 美国
• 起止时间: 2000-07-01 至 2006-08-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/6649221
• 关键词: DVD /CD ROM; clinical research; computer assisted medical decision making; computer human interaction; computer program /software; computer system design /evaluation; educational resource design /development; human subject; interactive multimedia; male; neoplasm /cancer education; neoplasm /cancer relapse /recurrence; neoplasm /cancer therapy; prostate neoplasms

DESCRIPTION (provided by applicant): An estimated 50-75% of men undergoing surgery or radiation treatment for prostate cancer will experience signs of recurrence within 10 years, prompting additional treatment decisions. The proposed Recurrent Prostate Cancer: Your Decision Notebook TM CD-ROM will provide information and interactive tools to focus patient learning and promote informed treatment decision-making. HealthMark completed the Phase I project aims, demonstrating the feasibility of producing a multimedia tool that improves patients' knowledge and increases self-efficacy of treatment decision-making processes. In Phase II, HealthMark will produce the remainder of the product's information and interactive decision-support tools. A National Medical Review Board will review the CD-ROM for accuracy and patient appropriateness. A two-group randomized field test will assess the programs' effectiveness at changing patients' knowledge, decision self-efficacy and decision satisfaction, while decreasing decision uncertainty.

描述（由申请人提供）：估计50-75%接受前列腺癌手术或放射治疗的男性将在10年内出现复发迹象，促使做出额外的治疗决定。拟议的复发性前列腺癌：您的决策笔记本TM光盘将提供信息和互动工具，以集中患者的学习和促进知情的治疗决策。HealthMark完成了第一阶段的项目目标，证明了制作一个多媒体工具的可行性，该工具可以提高患者的知识，并提高治疗决策过程的自我效能。在第二阶段，HealthMark将制作产品的其余信息和交互式决策支持工具。国家医学审查委员会将审查光盘的准确性和患者的适当性。两组随机现场测试将评估该计划在改变患者知识，决策自我效能和决策满意度方面的有效性，同时降低决策不确定性。